Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.

Neuro Oncol · 2023 · PMC10398799 · PMID 37010875

Europe PMC DOI

hedged sentence

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

did not reach statistical significanceP = 0.054so close (0.05 < p ≤ 0.1)

Hearing loss during maintenance was more common in pediatric participants (3/11 ears, 27%) than in adult patients (1/18 ears, 6%) although this did not reach statistical significance ( P = 0.054).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.